The protective effect of dexamethasone against radiation damage induced by interstitial irradiation in normal monkey brain.
OBJECTIVE
The protective effect of dexamethasone against radiation damage is unclear. We examined the effect of early treatment of high-dose dexamethasone on iridium-192-induced damage to normal brain tissue.


METHODS
Brain damage induced by interstitial irradiation with iridium-192 was evaluated with sequential magnetic resonance imaging and proton magnetic resonance spectroscopy in 11 adult monkeys, with or without short-term high-dose dexamethasone treatment. Dexamethasone (1 mg/kg of body weight/d) was administered intramuscularly to five irradiated animals every 24 hours, beginning 2 days before and ending 7 days after irradiation. Magnetic resonance imaging and proton magnetic resonance spectroscopy were performed 1 week, 1 month, and 3 months after irradiation.


RESULTS
Magnetic resonance imaging performed 1 week after irradiation revealed marked edema in five nontreated animals. In dexamethasone-treated animals, the volume of edema was reduced significantly, compared to that of nontreated animals, 1 week and 1 month after irradiation. The volume of ring enhancement in dexamethasone-treated animals was also reduced significantly, compared to that of nontreated animals, 3 months after the irradiation. Proton magnetic resonance spectroscopy spectra revealed that N-acetylaspartate and choline peaks were reduced 1 week after irradiation in both groups. However, there were no statistically significant differences between the two groups at any time points.


CONCLUSIONS
These results suggest that dexamethasone treatment may have an antiedema effect at an early stage and may modify subsequent development of vascular and inflammatory changes but may have no effect of preventing radiation-induced necrosis and the reduction of N-acetylaspartate after brachytherapy.
Tada
E
E
Department of Neurological Surgery, Okayama University Medical School, Japan.
Matsumoto
K
K
Kinoshita
K
K
Furuta
T
T
Ohmoto
T
T
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000378:metabolism; D001918:Brachytherapy; D001921:Brain / Q000473:pathology / Q000528:radiation effects*; D002794:Choline / Q000378:metabolism; D003907:Dexamethasone / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D007273:Injections, Intramuscular; D008251:Macaca; D009682:Magnetic Resonance Spectroscopy; D011292:Premedication; D011833:Radiation Injuries, Experimental / Q000473:pathology / Q000517:prevention & control*; D011837:Radiation-Protective Agents / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D011837:Radiation-Protective Agents; D001224:Aspartic Acid; D003907:Dexamethasone; C000179:N-acetylaspartate; D002794:Choline